Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Median Arcuate Ligament Syndrome | 7 | 2023 | 23 | 3.140 |
Why?
|
Myocytes, Smooth Muscle | 5 | 2015 | 132 | 1.680 |
Why?
|
Abdominal Pain | 6 | 2023 | 116 | 1.630 |
Why?
|
Celiac Artery | 4 | 2023 | 21 | 1.540 |
Why?
|
Muscle, Smooth, Vascular | 7 | 2015 | 238 | 1.460 |
Why?
|
Vascular Surgical Procedures | 8 | 2018 | 147 | 1.430 |
Why?
|
Tunica Intima | 5 | 2015 | 57 | 1.340 |
Why?
|
Blood Vessel Prosthesis Implantation | 14 | 2018 | 192 | 1.250 |
Why?
|
Peripheral Arterial Disease | 5 | 2018 | 76 | 1.150 |
Why?
|
Constriction, Pathologic | 3 | 2016 | 201 | 1.150 |
Why?
|
Carotid Stenosis | 7 | 2012 | 103 | 1.120 |
Why?
|
Arterial Occlusive Diseases | 4 | 2016 | 98 | 1.060 |
Why?
|
Stents | 7 | 2018 | 357 | 1.060 |
Why?
|
Herpesvirus 1, Human | 4 | 2015 | 243 | 0.970 |
Why?
|
Cell Proliferation | 4 | 2015 | 1545 | 0.900 |
Why?
|
Carotid Artery, Internal | 4 | 2012 | 65 | 0.850 |
Why?
|
Chronic Pain | 3 | 2018 | 114 | 0.840 |
Why?
|
Aortic Aneurysm, Abdominal | 4 | 2018 | 107 | 0.830 |
Why?
|
Decompression, Surgical | 3 | 2018 | 89 | 0.820 |
Why?
|
Endarterectomy, Carotid | 4 | 2012 | 69 | 0.800 |
Why?
|
Angioplasty, Balloon | 2 | 2009 | 96 | 0.680 |
Why?
|
Mental Disorders | 2 | 2018 | 362 | 0.680 |
Why?
|
Hyperplasia | 6 | 2015 | 144 | 0.660 |
Why?
|
Patient Reported Outcome Measures | 1 | 2018 | 135 | 0.650 |
Why?
|
Ultrasonography, Doppler, Duplex | 5 | 2019 | 44 | 0.640 |
Why?
|
Quality of Life | 4 | 2021 | 1401 | 0.640 |
Why?
|
Apoptosis | 3 | 2008 | 1655 | 0.630 |
Why?
|
Peripheral Vascular Diseases | 3 | 2013 | 59 | 0.580 |
Why?
|
Laparoscopy | 4 | 2018 | 684 | 0.580 |
Why?
|
Graft Occlusion, Vascular | 4 | 2018 | 98 | 0.570 |
Why?
|
Ligaments | 1 | 2013 | 30 | 0.510 |
Why?
|
Rabbits | 9 | 2015 | 657 | 0.500 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2013 | 62 | 0.480 |
Why?
|
Simplexvirus | 2 | 2012 | 153 | 0.470 |
Why?
|
Aortic Diseases | 3 | 2009 | 99 | 0.470 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2012 | 37 | 0.460 |
Why?
|
Mass Screening | 1 | 2016 | 597 | 0.440 |
Why?
|
Iliac Artery | 2 | 2009 | 34 | 0.440 |
Why?
|
Coronary Disease | 1 | 2013 | 271 | 0.440 |
Why?
|
Coronary Vessels | 1 | 2013 | 182 | 0.430 |
Why?
|
Leg | 5 | 2003 | 129 | 0.420 |
Why?
|
Carotid Arteries | 1 | 2012 | 126 | 0.420 |
Why?
|
Treatment Outcome | 18 | 2018 | 7589 | 0.410 |
Why?
|
Humans | 51 | 2023 | 81308 | 0.400 |
Why?
|
Aneurysm, False | 2 | 2007 | 53 | 0.400 |
Why?
|
Male | 40 | 2020 | 39770 | 0.390 |
Why?
|
Angioplasty | 2 | 2007 | 68 | 0.390 |
Why?
|
Carotid Artery Injuries | 1 | 2008 | 22 | 0.370 |
Why?
|
Veins | 5 | 2009 | 96 | 0.360 |
Why?
|
Endoleak | 3 | 2019 | 32 | 0.350 |
Why?
|
Blood Vessel Prosthesis | 5 | 2018 | 218 | 0.340 |
Why?
|
Calcinosis | 1 | 2009 | 232 | 0.340 |
Why?
|
Aneurysm, Infected | 1 | 2007 | 11 | 0.340 |
Why?
|
Brachial Artery | 1 | 2007 | 37 | 0.330 |
Why?
|
Exercise Therapy | 2 | 2018 | 65 | 0.330 |
Why?
|
Substance Abuse, Intravenous | 1 | 2007 | 49 | 0.330 |
Why?
|
Nicotinic Agonists | 1 | 2008 | 72 | 0.320 |
Why?
|
Risk Factors | 9 | 2018 | 5177 | 0.310 |
Why?
|
Nicotine | 1 | 2008 | 190 | 0.300 |
Why?
|
Hemodynamics | 5 | 2008 | 687 | 0.290 |
Why?
|
Vascular Patency | 8 | 2009 | 119 | 0.290 |
Why?
|
Time Factors | 11 | 2018 | 5161 | 0.270 |
Why?
|
Adolescent | 8 | 2020 | 8736 | 0.270 |
Why?
|
Female | 29 | 2019 | 42685 | 0.260 |
Why?
|
Inflammation Mediators | 2 | 2015 | 153 | 0.260 |
Why?
|
Thymectomy | 1 | 2003 | 24 | 0.260 |
Why?
|
Thoracoscopy | 1 | 2003 | 23 | 0.260 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 153 | 0.250 |
Why?
|
Genetic Vectors | 2 | 2003 | 429 | 0.250 |
Why?
|
Myasthenia Gravis | 1 | 2003 | 76 | 0.250 |
Why?
|
Ischemia | 5 | 2009 | 244 | 0.240 |
Why?
|
Saphenous Vein | 5 | 2002 | 59 | 0.240 |
Why?
|
Middle Aged | 22 | 2018 | 24127 | 0.240 |
Why?
|
Retrospective Studies | 15 | 2019 | 7600 | 0.230 |
Why?
|
Aged | 21 | 2018 | 17570 | 0.230 |
Why?
|
Blood Flow Velocity | 6 | 2019 | 196 | 0.230 |
Why?
|
Reoperation | 4 | 2013 | 573 | 0.230 |
Why?
|
Endovascular Procedures | 3 | 2020 | 172 | 0.230 |
Why?
|
Comorbidity | 4 | 2018 | 924 | 0.220 |
Why?
|
Unnecessary Procedures | 1 | 2002 | 51 | 0.220 |
Why?
|
Limb Salvage | 3 | 2009 | 30 | 0.210 |
Why?
|
Preoperative Care | 2 | 2013 | 388 | 0.210 |
Why?
|
Tomography, X-Ray Computed | 7 | 2013 | 2446 | 0.210 |
Why?
|
Walking | 2 | 2018 | 77 | 0.200 |
Why?
|
Vascular System Injuries | 1 | 2020 | 24 | 0.200 |
Why?
|
Foreign Bodies | 1 | 2020 | 57 | 0.200 |
Why?
|
Wounds, Gunshot | 1 | 2020 | 60 | 0.190 |
Why?
|
Aorta, Thoracic | 1 | 2020 | 165 | 0.190 |
Why?
|
Genetic Therapy | 1 | 2001 | 334 | 0.190 |
Why?
|
Vena Cava, Inferior | 1 | 2020 | 139 | 0.180 |
Why?
|
Cost of Illness | 2 | 2018 | 148 | 0.180 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2018 | 40 | 0.180 |
Why?
|
Follow-Up Studies | 6 | 2018 | 3586 | 0.180 |
Why?
|
Child | 4 | 2018 | 6639 | 0.180 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2008 | 64 | 0.170 |
Why?
|
Home Nursing | 1 | 2018 | 18 | 0.170 |
Why?
|
Wearable Electronic Devices | 1 | 2018 | 20 | 0.170 |
Why?
|
Caspase 3 | 2 | 2008 | 160 | 0.170 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 103 | 0.170 |
Why?
|
Lower Extremity | 3 | 2017 | 69 | 0.160 |
Why?
|
Computed Tomography Angiography | 1 | 2018 | 107 | 0.160 |
Why?
|
Mental Health | 1 | 2018 | 145 | 0.160 |
Why?
|
Femoral Artery | 3 | 2009 | 81 | 0.160 |
Why?
|
Pain Measurement | 1 | 2018 | 295 | 0.160 |
Why?
|
Thrombosis | 2 | 2014 | 273 | 0.160 |
Why?
|
Regional Blood Flow | 4 | 2018 | 199 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 849 | 0.150 |
Why?
|
Chi-Square Distribution | 2 | 2018 | 358 | 0.150 |
Why?
|
Kidney Transplantation | 1 | 2002 | 804 | 0.150 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2015 | 24 | 0.150 |
Why?
|
Aneurysm, Ruptured | 2 | 2006 | 50 | 0.150 |
Why?
|
Stress, Mechanical | 3 | 2008 | 245 | 0.150 |
Why?
|
Prospective Studies | 3 | 2018 | 3955 | 0.140 |
Why?
|
Animals | 10 | 2015 | 25878 | 0.140 |
Why?
|
Adult | 10 | 2018 | 24771 | 0.130 |
Why?
|
Carotid Artery, Common | 3 | 2008 | 28 | 0.130 |
Why?
|
Aged, 80 and over | 8 | 2019 | 6244 | 0.130 |
Why?
|
Enteric Nervous System | 1 | 2013 | 8 | 0.130 |
Why?
|
Proportional Hazards Models | 3 | 2012 | 830 | 0.130 |
Why?
|
Diaphragm | 1 | 2013 | 49 | 0.130 |
Why?
|
Jugular Veins | 3 | 2005 | 70 | 0.130 |
Why?
|
Sex Distribution | 1 | 2013 | 170 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2013 | 126 | 0.120 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 106 | 0.120 |
Why?
|
Mutation | 4 | 2012 | 3791 | 0.120 |
Why?
|
Leptospirosis | 1 | 2012 | 4 | 0.120 |
Why?
|
Embolization, Therapeutic | 2 | 2012 | 205 | 0.110 |
Why?
|
Hemostatics | 1 | 2012 | 54 | 0.110 |
Why?
|
Pediatrics | 1 | 2016 | 336 | 0.110 |
Why?
|
Vascular Resistance | 2 | 2002 | 99 | 0.110 |
Why?
|
Radiography | 4 | 2007 | 812 | 0.110 |
Why?
|
Disease Progression | 2 | 2015 | 1436 | 0.110 |
Why?
|
Aortography | 2 | 2009 | 57 | 0.110 |
Why?
|
Lumbosacral Plexus | 1 | 2011 | 7 | 0.110 |
Why?
|
Spinal Nerve Roots | 1 | 2011 | 17 | 0.110 |
Why?
|
Cell Movement | 1 | 2015 | 740 | 0.110 |
Why?
|
Young Adult | 3 | 2018 | 5754 | 0.110 |
Why?
|
Neurilemmoma | 1 | 2011 | 33 | 0.110 |
Why?
|
ras Proteins | 1 | 2012 | 127 | 0.110 |
Why?
|
Pelvic Neoplasms | 1 | 2011 | 42 | 0.110 |
Why?
|
Spinal Cord Neoplasms | 1 | 2011 | 46 | 0.100 |
Why?
|
Carotid Artery, External | 2 | 2008 | 8 | 0.100 |
Why?
|
Radiography, Interventional | 1 | 2012 | 148 | 0.100 |
Why?
|
Research Design | 1 | 2014 | 570 | 0.100 |
Why?
|
Patient Satisfaction | 1 | 2013 | 426 | 0.100 |
Why?
|
Environment | 1 | 2012 | 212 | 0.100 |
Why?
|
Chronic Disease | 1 | 2013 | 944 | 0.100 |
Why?
|
Atherectomy | 1 | 2009 | 4 | 0.100 |
Why?
|
Rupture | 1 | 2009 | 58 | 0.100 |
Why?
|
Cells, Cultured | 1 | 2015 | 2798 | 0.100 |
Why?
|
Multivariate Analysis | 1 | 2012 | 968 | 0.100 |
Why?
|
Shear Strength | 1 | 2008 | 19 | 0.090 |
Why?
|
Recurrence | 2 | 2002 | 1116 | 0.090 |
Why?
|
In Situ Nick-End Labeling | 1 | 2008 | 121 | 0.090 |
Why?
|
Popliteal Artery | 2 | 2006 | 26 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2018 | 1625 | 0.090 |
Why?
|
Polytetrafluoroethylene | 3 | 2002 | 69 | 0.080 |
Why?
|
Ligation | 1 | 2007 | 52 | 0.080 |
Why?
|
Collateral Circulation | 1 | 2007 | 34 | 0.080 |
Why?
|
Risk Assessment | 2 | 2012 | 2180 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 2 | 2006 | 248 | 0.080 |
Why?
|
Cell Line | 1 | 2012 | 2474 | 0.080 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2008 | 78 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 112 | 0.080 |
Why?
|
Blotting, Western | 1 | 2008 | 778 | 0.080 |
Why?
|
Brachiocephalic Trunk | 1 | 2006 | 14 | 0.080 |
Why?
|
Arteries | 1 | 2007 | 176 | 0.080 |
Why?
|
Survival Analysis | 4 | 2003 | 1521 | 0.070 |
Why?
|
Homeostasis | 1 | 2008 | 395 | 0.070 |
Why?
|
Stroke | 1 | 2012 | 768 | 0.070 |
Why?
|
Robotics | 1 | 2008 | 255 | 0.070 |
Why?
|
Pulsatile Flow | 2 | 2001 | 49 | 0.070 |
Why?
|
Models, Animal | 2 | 2001 | 254 | 0.060 |
Why?
|
Smoking | 1 | 2008 | 600 | 0.060 |
Why?
|
Thrombophilia | 1 | 2003 | 20 | 0.060 |
Why?
|
Blood Circulation | 1 | 2002 | 29 | 0.060 |
Why?
|
Iliac Aneurysm | 1 | 2002 | 6 | 0.060 |
Why?
|
Viscera | 1 | 2002 | 17 | 0.060 |
Why?
|
Radial Artery | 1 | 2002 | 25 | 0.060 |
Why?
|
Embolism | 1 | 2002 | 26 | 0.060 |
Why?
|
Prosthesis Design | 2 | 2018 | 269 | 0.060 |
Why?
|
Models, Cardiovascular | 1 | 2002 | 97 | 0.060 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2002 | 12 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2003 | 117 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2002 | 91 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 220 | 0.060 |
Why?
|
Organ Culture Techniques | 1 | 2001 | 132 | 0.050 |
Why?
|
Hemorheology | 1 | 2001 | 7 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2002 | 692 | 0.050 |
Why?
|
Postoperative Care | 1 | 2002 | 206 | 0.050 |
Why?
|
Signal Transduction | 1 | 2012 | 3167 | 0.050 |
Why?
|
Arteriosclerosis | 1 | 2001 | 158 | 0.050 |
Why?
|
Gene Transfer Techniques | 1 | 2001 | 148 | 0.050 |
Why?
|
Thoracotomy | 1 | 2020 | 56 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2015 | 1747 | 0.050 |
Why?
|
Heart Rate | 1 | 2002 | 493 | 0.050 |
Why?
|
Salvage Therapy | 1 | 2001 | 225 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2002 | 300 | 0.050 |
Why?
|
Transfection | 1 | 2001 | 892 | 0.050 |
Why?
|
Myocardial Contraction | 1 | 2001 | 242 | 0.050 |
Why?
|
Kidney Failure, Chronic | 2 | 2001 | 504 | 0.050 |
Why?
|
Hospital Costs | 1 | 2000 | 99 | 0.050 |
Why?
|
Sex Factors | 2 | 2018 | 1025 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2019 | 79 | 0.050 |
Why?
|
Chicago | 3 | 2015 | 1340 | 0.050 |
Why?
|
Blood Pressure | 2 | 2002 | 1163 | 0.040 |
Why?
|
Biomarkers | 2 | 2015 | 1617 | 0.040 |
Why?
|
Telephone | 1 | 2018 | 31 | 0.040 |
Why?
|
Retreatment | 1 | 2018 | 106 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2002 | 332 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2017 | 18 | 0.040 |
Why?
|
Walk Test | 1 | 2017 | 21 | 0.040 |
Why?
|
Pressure | 3 | 2002 | 147 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 2018 | 152 | 0.040 |
Why?
|
Surveys and Questionnaires | 2 | 2018 | 2310 | 0.040 |
Why?
|
Analgesics | 1 | 2018 | 115 | 0.040 |
Why?
|
Recovery of Function | 1 | 2018 | 251 | 0.040 |
Why?
|
Patient Compliance | 1 | 2018 | 223 | 0.040 |
Why?
|
Self Report | 1 | 2018 | 271 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2018 | 1698 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2018 | 476 | 0.040 |
Why?
|
Clinical Decision-Making | 1 | 2018 | 245 | 0.040 |
Why?
|
Telemedicine | 1 | 2018 | 144 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 1947 | 0.040 |
Why?
|
Stem Cells | 1 | 2017 | 343 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2002 | 2101 | 0.030 |
Why?
|
Rupture, Spontaneous | 2 | 2006 | 38 | 0.030 |
Why?
|
Registries | 1 | 2018 | 655 | 0.030 |
Why?
|
Hospitalization | 1 | 2000 | 770 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 1626 | 0.030 |
Why?
|
Up-Regulation | 1 | 2015 | 693 | 0.030 |
Why?
|
American Samoa | 1 | 2012 | 1 | 0.030 |
Why?
|
Geographic Information Systems | 1 | 2012 | 21 | 0.030 |
Why?
|
Seroepidemiologic Studies | 1 | 2012 | 53 | 0.030 |
Why?
|
Back Pain | 1 | 2011 | 37 | 0.030 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2011 | 55 | 0.030 |
Why?
|
Constipation | 1 | 2011 | 60 | 0.030 |
Why?
|
Odds Ratio | 1 | 2012 | 652 | 0.020 |
Why?
|
Logistic Models | 1 | 2012 | 1117 | 0.020 |
Why?
|
Length of Stay | 2 | 2002 | 658 | 0.020 |
Why?
|
Prognosis | 1 | 2015 | 3549 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 1419 | 0.020 |
Why?
|
Critical Illness | 1 | 2009 | 265 | 0.020 |
Why?
|
Surgery, Computer-Assisted | 1 | 2008 | 99 | 0.020 |
Why?
|
Vascular Fistula | 1 | 2006 | 12 | 0.020 |
Why?
|
Respiratory Tract Fistula | 1 | 2006 | 9 | 0.020 |
Why?
|
Angiography | 1 | 2007 | 201 | 0.020 |
Why?
|
Tracheal Diseases | 1 | 2006 | 12 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2006 | 38 | 0.020 |
Why?
|
Tracheostomy | 1 | 2006 | 41 | 0.020 |
Why?
|
Cohort Studies | 2 | 2003 | 2600 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2003 | 2187 | 0.020 |
Why?
|
ROC Curve | 1 | 2008 | 734 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 2006 | 143 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2012 | 2595 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2005 | 159 | 0.020 |
Why?
|
Umbilical Arteries | 1 | 2003 | 16 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 2005 | 168 | 0.020 |
Why?
|
Inguinal Canal | 1 | 2003 | 5 | 0.020 |
Why?
|
Sinoatrial Node | 1 | 2002 | 10 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2006 | 229 | 0.020 |
Why?
|
Macaca fascicularis | 1 | 2002 | 118 | 0.020 |
Why?
|
Serologic Tests | 1 | 2003 | 41 | 0.020 |
Why?
|
Rheology | 1 | 2002 | 40 | 0.010 |
Why?
|
Culture Media | 1 | 2002 | 144 | 0.010 |
Why?
|
Fourier Analysis | 1 | 2002 | 127 | 0.010 |
Why?
|
Polyethylene Terephthalates | 1 | 2002 | 17 | 0.010 |
Why?
|
Femoral Vein | 1 | 2002 | 35 | 0.010 |
Why?
|
Coronary Stenosis | 1 | 2002 | 39 | 0.010 |
Why?
|
Time | 1 | 2002 | 76 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2005 | 1016 | 0.010 |
Why?
|
Aorta, Abdominal | 1 | 2002 | 59 | 0.010 |
Why?
|
Perfusion | 1 | 2002 | 187 | 0.010 |
Why?
|
Triglycerides | 1 | 2002 | 231 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2002 | 182 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2002 | 234 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2002 | 215 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 2003 | 993 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2002 | 266 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 428 | 0.010 |
Why?
|
Cell Survival | 1 | 2003 | 960 | 0.010 |
Why?
|
Life Tables | 1 | 2000 | 48 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2002 | 217 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2002 | 323 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2001 | 287 | 0.010 |
Why?
|
Adenoviridae | 1 | 2001 | 345 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 705 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2000 | 146 | 0.010 |
Why?
|
Biomechanical Phenomena | 1 | 2001 | 432 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2000 | 322 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2001 | 900 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2001 | 724 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 3103 | 0.010 |
Why?
|
Survival Rate | 1 | 2003 | 1820 | 0.010 |
Why?
|
Graft Survival | 1 | 2001 | 869 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2001 | 1725 | 0.010 |
Why?
|
Brain | 1 | 2006 | 2053 | 0.010 |
Why?
|
Hypertension | 1 | 2001 | 1207 | 0.010 |
Why?
|